nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.194	0.419	CbGbCtD
Pilocarpine—CYP3A4—Cytarabine—lymphatic system cancer	0.0852	0.184	CbGbCtD
Pilocarpine—CYP3A4—Teniposide—lymphatic system cancer	0.084	0.182	CbGbCtD
Pilocarpine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0587	0.127	CbGbCtD
Pilocarpine—CYP3A4—Vincristine—lymphatic system cancer	0.0404	0.0874	CbGbCtD
Pilocarpine—Alopecia—Bleomycin—lymphatic system cancer	0.00142	0.00263	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00141	0.00263	CcSEcCtD
Pilocarpine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00141	0.00263	CcSEcCtD
Pilocarpine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00141	0.00262	CcSEcCtD
Pilocarpine—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00141	0.00262	CcSEcCtD
Pilocarpine—Herpes simplex—Methotrexate—lymphatic system cancer	0.0014	0.0026	CcSEcCtD
Pilocarpine—Glossitis—Methotrexate—lymphatic system cancer	0.0014	0.0026	CcSEcCtD
Pilocarpine—Body temperature increased—Teniposide—lymphatic system cancer	0.0014	0.0026	CcSEcCtD
Pilocarpine—Abdominal pain—Teniposide—lymphatic system cancer	0.0014	0.0026	CcSEcCtD
Pilocarpine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00139	0.00259	CcSEcCtD
Pilocarpine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00139	0.00259	CcSEcCtD
Pilocarpine—Sweating—Mitoxantrone—lymphatic system cancer	0.00139	0.00258	CcSEcCtD
Pilocarpine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00138	0.00257	CcSEcCtD
Pilocarpine—Haematuria—Mitoxantrone—lymphatic system cancer	0.00138	0.00257	CcSEcCtD
Pilocarpine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00138	0.00256	CcSEcCtD
Pilocarpine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00137	0.00254	CcSEcCtD
Pilocarpine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00136	0.00253	CcSEcCtD
Pilocarpine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00135	0.00251	CcSEcCtD
Pilocarpine—Visual impairment—Carmustine—lymphatic system cancer	0.00135	0.00251	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00134	0.00249	CcSEcCtD
Pilocarpine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00133	0.00247	CcSEcCtD
Pilocarpine—Pain—Fludarabine—lymphatic system cancer	0.00133	0.00247	CcSEcCtD
Pilocarpine—Constipation—Fludarabine—lymphatic system cancer	0.00133	0.00247	CcSEcCtD
Pilocarpine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00132	0.00246	CcSEcCtD
Pilocarpine—Eye disorder—Carmustine—lymphatic system cancer	0.00131	0.00243	CcSEcCtD
Pilocarpine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.0013	0.00242	CcSEcCtD
Pilocarpine—Hypersensitivity—Teniposide—lymphatic system cancer	0.0013	0.00242	CcSEcCtD
Pilocarpine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0013	0.00242	CcSEcCtD
Pilocarpine—Flushing—Carmustine—lymphatic system cancer	0.0013	0.00241	CcSEcCtD
Pilocarpine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00129	0.0024	CcSEcCtD
Pilocarpine—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00129	0.0024	CcSEcCtD
Pilocarpine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00128	0.00238	CcSEcCtD
Pilocarpine—Asthenia—Teniposide—lymphatic system cancer	0.00127	0.00236	CcSEcCtD
Pilocarpine—Melaena—Methotrexate—lymphatic system cancer	0.00126	0.00234	CcSEcCtD
Pilocarpine—Pruritus—Teniposide—lymphatic system cancer	0.00125	0.00232	CcSEcCtD
Pilocarpine—Arrhythmia—Carmustine—lymphatic system cancer	0.00125	0.00232	CcSEcCtD
Pilocarpine—Leukopenia—Bleomycin—lymphatic system cancer	0.00125	0.00232	CcSEcCtD
Pilocarpine—Alopecia—Carmustine—lymphatic system cancer	0.00124	0.0023	CcSEcCtD
Pilocarpine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00123	0.00228	CcSEcCtD
Pilocarpine—Vaginal infection—Methotrexate—lymphatic system cancer	0.00122	0.00226	CcSEcCtD
Pilocarpine—Cough—Bleomycin—lymphatic system cancer	0.00122	0.00226	CcSEcCtD
Pilocarpine—Diarrhoea—Teniposide—lymphatic system cancer	0.00121	0.00225	CcSEcCtD
Pilocarpine—Chest pain—Bleomycin—lymphatic system cancer	0.00119	0.00221	CcSEcCtD
Pilocarpine—Myalgia—Bleomycin—lymphatic system cancer	0.00119	0.00221	CcSEcCtD
Pilocarpine—Alopecia—Vincristine—lymphatic system cancer	0.00118	0.00219	CcSEcCtD
Pilocarpine—Back pain—Carmustine—lymphatic system cancer	0.00118	0.00219	CcSEcCtD
Pilocarpine—Discomfort—Bleomycin—lymphatic system cancer	0.00117	0.00218	CcSEcCtD
Pilocarpine—Chills—Mitoxantrone—lymphatic system cancer	0.00117	0.00217	CcSEcCtD
Pilocarpine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00116	0.00216	CcSEcCtD
Pilocarpine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00115	0.00214	CcSEcCtD
Pilocarpine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00115	0.00214	CcSEcCtD
Pilocarpine—Confusional state—Bleomycin—lymphatic system cancer	0.00115	0.00213	CcSEcCtD
Pilocarpine—Vision blurred—Carmustine—lymphatic system cancer	0.00115	0.00213	CcSEcCtD
Pilocarpine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00114	0.00213	CcSEcCtD
Pilocarpine—Tremor—Carmustine—lymphatic system cancer	0.00114	0.00212	CcSEcCtD
Pilocarpine—Oedema—Bleomycin—lymphatic system cancer	0.00114	0.00212	CcSEcCtD
Pilocarpine—Infection—Bleomycin—lymphatic system cancer	0.00113	0.0021	CcSEcCtD
Pilocarpine—Back pain—Vincristine—lymphatic system cancer	0.00112	0.00209	CcSEcCtD
Pilocarpine—Vomiting—Teniposide—lymphatic system cancer	0.00112	0.00209	CcSEcCtD
Pilocarpine—Agitation—Carmustine—lymphatic system cancer	0.00112	0.00208	CcSEcCtD
Pilocarpine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00111	0.00207	CcSEcCtD
Pilocarpine—Asthenia—Fludarabine—lymphatic system cancer	0.00111	0.00207	CcSEcCtD
Pilocarpine—Rash—Teniposide—lymphatic system cancer	0.00111	0.00207	CcSEcCtD
Pilocarpine—Dermatitis—Teniposide—lymphatic system cancer	0.00111	0.00207	CcSEcCtD
Pilocarpine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00111	0.00206	CcSEcCtD
Pilocarpine—Headache—Teniposide—lymphatic system cancer	0.00111	0.00206	CcSEcCtD
Pilocarpine—Pruritus—Fludarabine—lymphatic system cancer	0.0011	0.00204	CcSEcCtD
Pilocarpine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.0011	0.00204	CcSEcCtD
Pilocarpine—Back pain—Mitoxantrone—lymphatic system cancer	0.00109	0.00204	CcSEcCtD
Pilocarpine—Leukopenia—Carmustine—lymphatic system cancer	0.00109	0.00203	CcSEcCtD
Pilocarpine—Anorexia—Bleomycin—lymphatic system cancer	0.00109	0.00202	CcSEcCtD
Pilocarpine—Agitation—Vincristine—lymphatic system cancer	0.00107	0.00199	CcSEcCtD
Pilocarpine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00107	0.00198	CcSEcCtD
Pilocarpine—Hypotension—Bleomycin—lymphatic system cancer	0.00106	0.00198	CcSEcCtD
Pilocarpine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00106	0.00198	CcSEcCtD
Pilocarpine—Hypertension—Carmustine—lymphatic system cancer	0.00105	0.00195	CcSEcCtD
Pilocarpine—Nausea—Teniposide—lymphatic system cancer	0.00105	0.00195	CcSEcCtD
Pilocarpine—Leukopenia—Vincristine—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Pilocarpine—Chest pain—Carmustine—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Pilocarpine—Myalgia—Carmustine—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Pilocarpine—Anxiety—Carmustine—lymphatic system cancer	0.00103	0.00192	CcSEcCtD
Pilocarpine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00102	0.0019	CcSEcCtD
Pilocarpine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00101	0.00189	CcSEcCtD
Pilocarpine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00101	0.00188	CcSEcCtD
Pilocarpine—Hypertension—Vincristine—lymphatic system cancer	0.001	0.00187	CcSEcCtD
Pilocarpine—Confusional state—Carmustine—lymphatic system cancer	0.001	0.00186	CcSEcCtD
Pilocarpine—Oedema—Carmustine—lymphatic system cancer	0.000994	0.00185	CcSEcCtD
Pilocarpine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000992	0.00185	CcSEcCtD
Pilocarpine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00099	0.00184	CcSEcCtD
Pilocarpine—Myalgia—Vincristine—lymphatic system cancer	0.00099	0.00184	CcSEcCtD
Pilocarpine—Cough—Mitoxantrone—lymphatic system cancer	0.000988	0.00184	CcSEcCtD
Pilocarpine—Infection—Carmustine—lymphatic system cancer	0.000987	0.00184	CcSEcCtD
Pilocarpine—Vomiting—Fludarabine—lymphatic system cancer	0.000987	0.00184	CcSEcCtD
Pilocarpine—Rash—Fludarabine—lymphatic system cancer	0.000979	0.00182	CcSEcCtD
Pilocarpine—Dermatitis—Fludarabine—lymphatic system cancer	0.000978	0.00182	CcSEcCtD
Pilocarpine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000977	0.00182	CcSEcCtD
Pilocarpine—Pain—Bleomycin—lymphatic system cancer	0.000973	0.00181	CcSEcCtD
Pilocarpine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000973	0.00181	CcSEcCtD
Pilocarpine—Headache—Fludarabine—lymphatic system cancer	0.000973	0.00181	CcSEcCtD
Pilocarpine—Tachycardia—Carmustine—lymphatic system cancer	0.00097	0.0018	CcSEcCtD
Pilocarpine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000964	0.00179	CcSEcCtD
Pilocarpine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000964	0.00179	CcSEcCtD
Pilocarpine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000964	0.00179	CcSEcCtD
Pilocarpine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00096	0.00179	CcSEcCtD
Pilocarpine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000952	0.00177	CcSEcCtD
Pilocarpine—Oedema—Vincristine—lymphatic system cancer	0.000949	0.00176	CcSEcCtD
Pilocarpine—Anorexia—Carmustine—lymphatic system cancer	0.000947	0.00176	CcSEcCtD
Pilocarpine—Infection—Vincristine—lymphatic system cancer	0.000942	0.00175	CcSEcCtD
Pilocarpine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000938	0.00174	CcSEcCtD
Pilocarpine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000931	0.00173	CcSEcCtD
Pilocarpine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000929	0.00173	CcSEcCtD
Pilocarpine—Hypotension—Carmustine—lymphatic system cancer	0.000929	0.00173	CcSEcCtD
Pilocarpine—Oedema—Mitoxantrone—lymphatic system cancer	0.000924	0.00172	CcSEcCtD
Pilocarpine—Nausea—Fludarabine—lymphatic system cancer	0.000922	0.00171	CcSEcCtD
Pilocarpine—Infection—Mitoxantrone—lymphatic system cancer	0.000918	0.00171	CcSEcCtD
Pilocarpine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000917	0.00171	CcSEcCtD
Pilocarpine—Shock—Mitoxantrone—lymphatic system cancer	0.000909	0.00169	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000905	0.00168	CcSEcCtD
Pilocarpine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000904	0.00168	CcSEcCtD
Pilocarpine—Anorexia—Vincristine—lymphatic system cancer	0.000904	0.00168	CcSEcCtD
Pilocarpine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000902	0.00168	CcSEcCtD
Pilocarpine—Body temperature increased—Bleomycin—lymphatic system cancer	0.0009	0.00167	CcSEcCtD
Pilocarpine—Insomnia—Carmustine—lymphatic system cancer	0.000899	0.00167	CcSEcCtD
Pilocarpine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000893	0.00166	CcSEcCtD
Pilocarpine—Paraesthesia—Carmustine—lymphatic system cancer	0.000892	0.00166	CcSEcCtD
Pilocarpine—Mood swings—Methotrexate—lymphatic system cancer	0.000887	0.00165	CcSEcCtD
Pilocarpine—Hypotension—Vincristine—lymphatic system cancer	0.000886	0.00165	CcSEcCtD
Pilocarpine—Dyspnoea—Carmustine—lymphatic system cancer	0.000886	0.00165	CcSEcCtD
Pilocarpine—Somnolence—Carmustine—lymphatic system cancer	0.000883	0.00164	CcSEcCtD
Pilocarpine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000881	0.00164	CcSEcCtD
Pilocarpine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000865	0.00161	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000864	0.00161	CcSEcCtD
Pilocarpine—Decreased appetite—Carmustine—lymphatic system cancer	0.000864	0.00161	CcSEcCtD
Pilocarpine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000863	0.00161	CcSEcCtD
Pilocarpine—Insomnia—Vincristine—lymphatic system cancer	0.000858	0.0016	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000858	0.0016	CcSEcCtD
Pilocarpine—Paraesthesia—Vincristine—lymphatic system cancer	0.000852	0.00158	CcSEcCtD
Pilocarpine—Constipation—Carmustine—lymphatic system cancer	0.00085	0.00158	CcSEcCtD
Pilocarpine—Pain—Carmustine—lymphatic system cancer	0.00085	0.00158	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000842	0.00156	CcSEcCtD
Pilocarpine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000839	0.00156	CcSEcCtD
Pilocarpine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00083	0.00154	CcSEcCtD
Pilocarpine—Decreased appetite—Vincristine—lymphatic system cancer	0.000825	0.00153	CcSEcCtD
Pilocarpine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000824	0.00153	CcSEcCtD
Pilocarpine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000821	0.00153	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000819	0.00152	CcSEcCtD
Pilocarpine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000819	0.00152	CcSEcCtD
Pilocarpine—Asthenia—Bleomycin—lymphatic system cancer	0.000817	0.00152	CcSEcCtD
Pilocarpine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000813	0.00151	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000813	0.00151	CcSEcCtD
Pilocarpine—Constipation—Vincristine—lymphatic system cancer	0.000811	0.00151	CcSEcCtD
Pilocarpine—Pain—Vincristine—lymphatic system cancer	0.000811	0.00151	CcSEcCtD
Pilocarpine—Pruritus—Bleomycin—lymphatic system cancer	0.000805	0.0015	CcSEcCtD
Pilocarpine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000803	0.00149	CcSEcCtD
Pilocarpine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000794	0.00148	CcSEcCtD
Pilocarpine—Pain—Mitoxantrone—lymphatic system cancer	0.00079	0.00147	CcSEcCtD
Pilocarpine—Constipation—Mitoxantrone—lymphatic system cancer	0.00079	0.00147	CcSEcCtD
Pilocarpine—Abdominal pain—Carmustine—lymphatic system cancer	0.000786	0.00146	CcSEcCtD
Pilocarpine—Body temperature increased—Carmustine—lymphatic system cancer	0.000786	0.00146	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000776	0.00144	CcSEcCtD
Pilocarpine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000761	0.00142	CcSEcCtD
Pilocarpine—Dysuria—Methotrexate—lymphatic system cancer	0.000757	0.00141	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000755	0.0014	CcSEcCtD
Pilocarpine—Abdominal pain—Vincristine—lymphatic system cancer	0.00075	0.00139	CcSEcCtD
Pilocarpine—Body temperature increased—Vincristine—lymphatic system cancer	0.00075	0.00139	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000739	0.00137	CcSEcCtD
Pilocarpine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000732	0.00136	CcSEcCtD
Pilocarpine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00073	0.00136	CcSEcCtD
Pilocarpine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00073	0.00136	CcSEcCtD
Pilocarpine—Pneumonia—Methotrexate—lymphatic system cancer	0.000726	0.00135	CcSEcCtD
Pilocarpine—Vomiting—Bleomycin—lymphatic system cancer	0.000724	0.00135	CcSEcCtD
Pilocarpine—Rash—Bleomycin—lymphatic system cancer	0.000718	0.00133	CcSEcCtD
Pilocarpine—Dermatitis—Bleomycin—lymphatic system cancer	0.000717	0.00133	CcSEcCtD
Pilocarpine—Asthenia—Carmustine—lymphatic system cancer	0.000713	0.00133	CcSEcCtD
Pilocarpine—Stomatitis—Methotrexate—lymphatic system cancer	0.000703	0.00131	CcSEcCtD
Pilocarpine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000701	0.0013	CcSEcCtD
Pilocarpine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000699	0.0013	CcSEcCtD
Pilocarpine—Sweating—Methotrexate—lymphatic system cancer	0.000692	0.00129	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—lymphatic system cancer	0.000688	0.00128	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—lymphatic system cancer	0.000681	0.00127	CcSEcCtD
Pilocarpine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000681	0.00127	CcSEcCtD
Pilocarpine—Asthenia—Vincristine—lymphatic system cancer	0.000681	0.00127	CcSEcCtD
Pilocarpine—Diarrhoea—Carmustine—lymphatic system cancer	0.00068	0.00126	CcSEcCtD
Pilocarpine—Nausea—Bleomycin—lymphatic system cancer	0.000676	0.00126	CcSEcCtD
Pilocarpine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000663	0.00123	CcSEcCtD
Pilocarpine—Dizziness—Carmustine—lymphatic system cancer	0.000657	0.00122	CcSEcCtD
Pilocarpine—Diarrhoea—Vincristine—lymphatic system cancer	0.000649	0.00121	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—lymphatic system cancer	0.000648	0.0012	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000643	0.0012	CcSEcCtD
Pilocarpine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000632	0.00118	CcSEcCtD
Pilocarpine—Vomiting—Carmustine—lymphatic system cancer	0.000632	0.00117	CcSEcCtD
Pilocarpine—Dizziness—Vincristine—lymphatic system cancer	0.000627	0.00117	CcSEcCtD
Pilocarpine—Rash—Carmustine—lymphatic system cancer	0.000627	0.00116	CcSEcCtD
Pilocarpine—Dermatitis—Carmustine—lymphatic system cancer	0.000626	0.00116	CcSEcCtD
Pilocarpine—Visual impairment—Methotrexate—lymphatic system cancer	0.000624	0.00116	CcSEcCtD
Pilocarpine—Headache—Carmustine—lymphatic system cancer	0.000623	0.00116	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—lymphatic system cancer	0.000605	0.00113	CcSEcCtD
Pilocarpine—Tinnitus—Methotrexate—lymphatic system cancer	0.000604	0.00112	CcSEcCtD
Pilocarpine—Vomiting—Vincristine—lymphatic system cancer	0.000603	0.00112	CcSEcCtD
Pilocarpine—Rash—Vincristine—lymphatic system cancer	0.000598	0.00111	CcSEcCtD
Pilocarpine—Dermatitis—Vincristine—lymphatic system cancer	0.000598	0.00111	CcSEcCtD
Pilocarpine—Headache—Vincristine—lymphatic system cancer	0.000594	0.0011	CcSEcCtD
Pilocarpine—Nausea—Carmustine—lymphatic system cancer	0.00059	0.0011	CcSEcCtD
Pilocarpine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000587	0.00109	CcSEcCtD
Pilocarpine—Rash—Mitoxantrone—lymphatic system cancer	0.000582	0.00108	CcSEcCtD
Pilocarpine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000582	0.00108	CcSEcCtD
Pilocarpine—Chills—Methotrexate—lymphatic system cancer	0.000581	0.00108	CcSEcCtD
Pilocarpine—Headache—Mitoxantrone—lymphatic system cancer	0.000579	0.00108	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—lymphatic system cancer	0.000572	0.00106	CcSEcCtD
Pilocarpine—Nausea—Vincristine—lymphatic system cancer	0.000563	0.00105	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000552	0.00103	CcSEcCtD
Pilocarpine—Nausea—Mitoxantrone—lymphatic system cancer	0.000549	0.00102	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—lymphatic system cancer	0.000546	0.00101	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—lymphatic system cancer	0.000531	0.000988	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—lymphatic system cancer	0.000505	0.000939	CcSEcCtD
Pilocarpine—Cough—Methotrexate—lymphatic system cancer	0.000492	0.000915	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—lymphatic system cancer	0.00048	0.000893	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—lymphatic system cancer	0.00048	0.000893	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—lymphatic system cancer	0.00048	0.000893	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—lymphatic system cancer	0.000474	0.000882	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—lymphatic system cancer	0.000464	0.000863	CcSEcCtD
Pilocarpine—Infection—Methotrexate—lymphatic system cancer	0.000457	0.00085	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000451	0.000838	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000445	0.000827	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—lymphatic system cancer	0.000439	0.000816	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—lymphatic system cancer	0.00043	0.0008	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000419	0.00078	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—lymphatic system cancer	0.000416	0.000774	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000413	0.000768	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00041	0.000763	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—lymphatic system cancer	0.000409	0.000761	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000405	0.000753	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—lymphatic system cancer	0.0004	0.000744	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000397	0.000739	CcSEcCtD
Pilocarpine—Pain—Methotrexate—lymphatic system cancer	0.000394	0.000732	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000379	0.000705	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000376	0.0007	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000364	0.000677	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000364	0.000677	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000339	0.000631	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—lymphatic system cancer	0.00033	0.000614	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—lymphatic system cancer	0.000326	0.000605	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000315	0.000586	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—lymphatic system cancer	0.000304	0.000566	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—lymphatic system cancer	0.000293	0.000544	CcSEcCtD
Pilocarpine—Rash—Methotrexate—lymphatic system cancer	0.00029	0.00054	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—lymphatic system cancer	0.00029	0.000539	CcSEcCtD
Pilocarpine—Headache—Methotrexate—lymphatic system cancer	0.000288	0.000536	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—lymphatic system cancer	0.000273	0.000508	CcSEcCtD
